← Back to Intel
Insider ActivityAPRE
Peters Richard, Director at Aprea Therapeutics, Inc., bought $100K of APRE
Updated Jun 13, 2026
Peters Richard
Director
Aprea Therapeutics, Inc. ·
$APRE
Transaction Details
| Insider | Peters Richard |
|---|---|
| Title | Director |
| Company | Aprea Therapeutics, Inc. |
| Ticker | APRE |
| Transaction Type | Purchase |
| Transaction Date | 2026-03-31 |
| Shares Traded | 123,915 |
| Price Per Share | $0.807 |
| Total Value | $100K |
| Filed Date | 2026-04-01 |
| Accession Number | 0001104659-26-038518 |
Ownership Context
| Shares Owned After Transaction | — |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001104659-26-038518
Other Insider Trades — APRE
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | bought | $25K | 2026-03-31 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for APRE — Aprea Therapeutics, Inc. →
Track APRE insider activity in real time on The Wire →
Get alerts when Peters Richard files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 13, 2026 at 07:19 UTC